Leukemia: all 5,475 studies
Page 45 of 55. Open to participants first (629), then studies with results posted, then the rest; newest registration first within each.
- Obatoclax, Fludarabine, and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic LeukemiaTerminatedNCT00612612Phase 1
- Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By SurgeryCompletedNCT00608361Phase 1
- Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With RadiotherapyCompletedNCT00606216
- T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic CancerCompletedNCT00602693Phase 1
- A Multi-Center Phase 2 Study of VEGF Trap as a Single Agent in Acute Myeloid LeukemiaWithdrawnNCT00601991Phase 2
- Liposomal Anthracyclin in the Treatment of Elderly ALLCompletedNCT00600977Phase 2
- A Phase I/II Study of GX15-070MS in Untreated CLLCompletedNCT00600964Phase 1
- Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)Status unknownNCT00598624Phase 2
- Study of Immune Responses to Influenza Vaccination With or Without Imiquimod Application in Untreated CLL PatientsTerminatedNCT00596336Phase 2
- A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid LeukemiaWithdrawnNCT00594555Phase 2
- Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)CompletedNCT00593944Phase 1
- A Phase I Trial of ZIO-101 in Hematologic CancersCompletedNCT00592046Phase 1
- A Randomized Trial Assessing the Roles of AraC in Newly Diagnosed APL Promyelocytic Leukemia (APL)CompletedNCT00591526Phase 3
- Adding Lomustine to Chemotherapy in Older Patients With Acute Myelogenous Leukemia (AML), and Allogeneic Transplantation for Patients From 60 to 65 Years OldCompletedNCT00590837Phase 3
- Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative DisordersCompletedNCT00588991Phase 1
- Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal TumorsCompletedNCT00580281Not applicable
- Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial CancersActive, not recruitingNCT00579163
- Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT00577694Phase 1
- Palifermin After Haploidentical PBSCTWithdrawnNCT00570999Phase 2
- Investigation of the Cylex® ImmuKnow® AssayCompletedNCT00569842
- A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid MalignanciesTerminatedNCT00569179Phase 1
- Adipokines as Predictors of the Metabolic Syndrome in ALL SurvivorsStatus unknownNCT00566566
- A Pilot Trial With Subcutaneous Alemtuzumab and Oral Fludarabinephosphate for the Determination of Safety, Efficacy and Molecular Profiling for the Prediction of ResponseCompletedNCT00565981Phase 2
- Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMPCompletedNCT00564512Phase 3
- Oral Valganciclovir Versus ValacyclovirCompletedNCT00562770Phase 2
- Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL PatientsCompletedNCT00559624Phase 1/2
- FLAG+Ida With G-CSF Priming for Patients Younger Than 60 Years With Resistant AMLStatus unknownNCT00559221Phase 2
- A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic LeukemiaCompletedNCT00559091Phase 2
- A Case-Cohort Study of Hematopoietic Malignancies and Related Disorders and Lung Cancer in Benzene-Exposed Workers in ChinaCompletedNCT00559065
- Dose Escalation Study of Gleevec and Chlorambucil in Previously Treated Chronic Lymphocytic Leukemia PatientsTerminatedNCT00558961Phase 1/2
- A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological MalignancyCompletedNCT00558675Phase 1/2
- High-dose Methylprednisolone and Rituximab in High Risk B-CLLCompletedNCT00558181Phase 2
- Physical Activity in Older Patients With Acute Myeloid Leukemia Undergoing ChemotherapyCompletedNCT00554489Not applicable
- Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old ChildrenCompletedNCT00552825
- Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin LymphomaWithdrawnNCT00551239Phase 3
- Different Therapies in Treating Infants With Newly Diagnosed Acute LeukemiaStatus unknownNCT00550992Not applicable
- Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLLCompletedNCT00546793Phase 1/2
- Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid LeukemiaStatus unknownNCT00544999Phase 1
- Dose Escalation Safety and Pharmacokinetic Study of AVE9633 as Single Agent in Relapsed/Refractory CD33-Positive Acute Myeloid LeukemiaTerminatedNCT00543972Phase 1
- Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLLTerminatedNCT00543114Phase 1
- Natural Killer Cells in Older Patients With Acute Myeloid LeukemiaCompletedNCT00540956Not applicable
- Phase I Epigenetic Priming Using Decitabine With Induction Chemotherapy in AMLCompletedNCT00538876Phase 1
- Prospective Database for Chronic Myelogenous LeukemiaStatus unknownNCT00538447Not applicable
- Prospective Database for Acute Myeloblastic LeukemiaStatus unknownNCT00538278Not applicable
- An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic PhaseCompletedNCT00538109Not applicable
- Reduced Intensity AlloSCT in(CML) With Persistent DiseaseTerminatedNCT00531310Phase 2
- Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML)CompletedNCT00530699Phase 1
- Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALLCompletedNCT00529360Phase 1/2
- Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous LeukemiaCompletedNCT00528983Phase 1
- A Study of Lintuzumab (SGN-33) in Combination With Low Dose Cytarabine in Patients 60+ Years With AMLCompletedNCT00528333Phase 2
- LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic LeukemiaCompletedNCT00526409Phase 4
- LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia PositiveCompletedNCT00526305Phase 4
- Functional Pharmacogenomics of Childhood Acute Lymphoblastic Leukemia in TaiwanStatus unknownNCT00526084
- Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS)Active, not recruitingNCT00525746
- HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic LeukemiaTerminatedNCT00524667Phase 2
- Study to Assess the Safety of Escalating Doses of AT9283, in Patients With LeukemiasTerminatedNCT00522990Phase 1/2
- A Trial Comparing a Prophylactic With a Therapeutic Platelet Transfusion Strategy in Two GroupsCompletedNCT00521664Phase 3
- Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseCompletedNCT00521430Not applicable
- Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APLCompletedNCT00520208Phase 2
- Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic LeukemiaStatus unknownNCT00517712Phase 2/3
- This Study is Being Performed to Evaluate the Effect of Genasense on the Efficacy and the Safety of Rituximab/Fludarabine Combination Treatment in Previously Untreated Subjects With Chronic Lymphocyctic Leukemia(CLL)WithdrawnNCT00517218Phase 3
- Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeCompletedNCT00516828Phase 1/2
- Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCTCompletedNCT00516152Phase 2
- Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia in Accelerated and Blastic PhaseCompletedNCT00514969Phase 2
- Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic MalignanciesTerminatedNCT00514722Not applicable
- Study of the Safety of GCS-100 in Subjects With Chronic Lymphocytic LeukemiaCompletedNCT00514696Phase 2
- Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day)CompletedNCT00514488Phase 3
- Feasibility Study of Acute Myelogenous Leukemia mRNA Plus Lysate Loaded Dendritic Cell VaccinesTerminatedNCT00514189Phase 1
- Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic MalignanciesTerminatedNCT00513318
- Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic AnemiaCompletedNCT00513175
- Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid LeukemiaCompletedNCT00512083Phase 2
- Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid LeukemiaCompletedNCT00511303Phase 2
- Study of the Combination of a Tyrosine Kinase Inhibitor (STI571) and a Pegylated Human Recombinant Interferon alfa2b (PEGINTRON)TerminatedNCT00511121Phase 2
- Velcade (Bortezomib - PS341) in the Treatment of Patients Over 18 Years With Ph+ LeukemiaCompletedNCT00511069Phase 2
- Study to Assess the Safety, Tolerability, and Efficacy of Tipifarnib Plus Bortezomib in the Treatment of Acute Myeloid LeukemiaStatus unknownNCT00510939Phase 2
- Exploratory Study of IMATINIB High Dose in Intermediate Risk Chronic Myeloid Leukemia in Chronic PhaseCompletedNCT00510926Phase 2
- Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell TransplantCompletedNCT00510315
- VELCADE in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous LeukemiaCompletedNCT00505700Phase 1
- Urban Environmental Exposures and Childhood CancerCompletedNCT00505141
- Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome PatientsCompletedNCT00504920
- Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)CompletedNCT00504764Phase 4
- R-CHOP and Alemtuzumab in Patients With Chronic Lymphocytic LeukemiaWithdrawnNCT00504491Phase 2
- Genetic Study of Chronic Lymphocytic Leukemia FamiliesStatus unknownNCT00503256
- Molecular Epidemiology of Acute Myelogenous LeukemiaStatus unknownNCT00502983
- Exercise Program for Adolescents and Young Adults With CancerCompletedNCT00502749Not applicable
- Prophylaxis of Fungal Invasive Infections in LeukemiaCompletedNCT00501098Phase 2
- A Phase I Dose Escalation Combination Study in Patients With Chronic Myelogenous Leukemia (CML) and Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)(0457-009)(TERMINATED)TerminatedNCT00500006Phase 1
- Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver DysfunctionCompletedNCT00499811Phase 1
- Physical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT00499785
- Individualized Exercise Programs for Patients Receiving Chemotherapy for Newly Diagnosed Acute or Relapsed Myeloid Leukemia or Lymphoblastic LeukemiaCompletedNCT00499759Not applicable
- Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With CancerWithdrawnNCT00499668Not applicable
- A Trial of GS-9219 in Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM)TerminatedNCT00499239Phase 1/2
- Cord Blood Expansion on Mesenchymal Stem CellsCompletedNCT00498316Phase 1
- Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid LeukemiaCompletedNCT00497991Phase 1
- A Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaTerminatedNCT00496132Phase 1/2
- PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic LeukemiaCompletedNCT00494897Phase 4
- Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM)CompletedNCT00493129Phase 2
- Treosulfan-based Conditioning for Transplantation in AML/MDSCompletedNCT00491634Phase 2
- Children's Resiliency, Adjustment, and CopingCompletedNCT00489632
- Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00489203Phase 2